货号：DT2025061966
CAS：1346598-19-3
规格：mg(更多包装需求请咨询客服)
纯度：≥98%
生产商：试剂家

生物活性：Glycidyl stearate-d5 is a deuterium labeled Glycidyl stearate (HY-W011188). Oxiran-2-ylmethyl stearate is a compound belonging to the class of esters. It contains reactive oxirane or epoxy groups that give the molecule its unique properties. Oxiran-2-ylmethyl stearate is derived from stearic acid and epichlorohydrin, which are naturally occurring substances. Glycidyl stearate is commonly used in various industrial applications such as the production of coatings, adhesives and surfactants. It can also be used as a crosslinking agent in the manufacture of polymers and resins.
体外研究(In Vitro)：氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。
试剂家 has not independently confirmed the accuracy of these methods. They are for reference only.
Glycidyl stearate-d5 相关抗体:
Mouse IgG Isotype Control
6X His-tag (C-terminal) Antibody (YA860)
DYKDDDDK Tag (FLAG) Antibody
GFP Antibody
Myc-tag Antibody
HA tag Antibody (YA856)
GST-Tag Antibody HRP Conjugated
V5-tag Antibody
Collagen I alpha 2 Antibody
Rabbit IgG Isotype Control
6X His Tag (C-terminal) Antibody
His Tag Antibody (HRP) (YA877)
HA Tag Antibody (HRP) (YA876)
EYFP Tag Antibody (YA872)
HSV Tag Antibody (YA878)
MBP Tag Antibody (YA879)
RFP Tag Antibody (YA882)
S Tag Antibody (YA883)
SRT Tag Antibody (YA884)
Strep-Tag II Antibody (YA885)
TAP Tag Antibody (YA887)
Collagen II Antibody
Collagen III Antibody
Collagen X Antibody
Collagen IV Antibody
Collagen I Antibody
Collagen VI alpha 1/2/3 Antibody (YA2637)
AmCyan Tag Antibody (YA864)
DsbA Tag Antibody (YA868)
E2 Tag Antibody (YA870)
分子量：345.57
Formula：C21H35D5O3
CAS 号：1346598-19-3
非标记 CAS：7460-84-6
性状：固体
颜色：White to off-white
运输条件：Room temperature in continental US; may vary elsewhere.
储存方式：Powder：-20°C：3 years，4°C：2 years
In solvent：-80°C：6 months，-20°C：1 month
纯度 & 产品资料
Data Sheet (535 KB)
产品使用指南 (1538 KB)
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-246.
 [Content Brief]